Opiant Pharmaceuticals Inc
OPNT
Get informed when a big investor buys or sells
+ FollowMarket Cap$108.8M
Close$
$26.89
30.2% upside
Current Fair Value
30.2% upsideUndervalued by 30.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $108.80 Million |
|---|---|
| Enterprise Value | $89.94 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.68 |
| Beta | 0.83 |
| Outstanding Shares | 5,138,000 |
Return
| Return on Equity | -163.34% |
|---|---|
| Return on Assets | -79.83% |
| Return on Invested Capital | -90.24% |
Valuation & Multiples
| P/E Ratio | 30.58 |
|---|---|
| PEG | -7.84 |
| Price to Sales | 0.56 |
| Price to Book Ratio | 6.88 |
| Enterprise Value to Revenue | 0.47 |
| Enterprise Value to EBIT | -2.85 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.18 |
| Debt to Equity | 0.81 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data